Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
CMIC is providing monitoring services as a CRO for Avigan® for phase III clinical trial in Japan led by FUJIFILM Toyama Chemical and will support for manufacturing the product as a CDMO.
Lead Product(s): Favipiravir
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Phase IIIProduct Type: Small molecule
Partner/Sponsor/Collaborator: FUJIFILM Toyama Chemical
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement April 23, 2020